Friendly bacteria cream for mild to moderate acne
Part of Skin clinical trials.
This trial tests a special cream made from a friendly bacteria (Lactobacillus) that is coated to help it stick to the skin. It is for people with mild to moderate acne who have not taken other acne treatments recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 33 years old.
- You have mild to moderate acne (Grade 1 to 3 on a scale of 1 to 4).
- You have at least 10 red, inflamed pimples on your face right now.
- You have not taken any antibiotic pills or creams for acne in the past month.
- You have not used any prescription acne pills like Accutane in the past 3 months.
- You have not had any other acne treatment (like laser, chemical peels, or creams) in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cream containing ubiquinol, pomegranate peel extract, ceramide, and salicylic acid on people with mild-to-moderate acne. The goal is to see how it improves skin condition.
This study tests whether taking a probiotic supplement can improve acne by balancing the gut microbiome. You will be asked to take the supplement and attend follow-up visits to track changes in your skin.
This trial tests skincare products designed for people with sensitive skin who have mild to moderate acne. The goal is to see if they safely and effectively reduce acne without irritating sensitive skin.
This study tests a cosmetic product alongside a standard prescription acne treatment for 12 weeks, then a maintenance phase to see if the product helps improve acne and skin appearance.
This early-stage study tests a new drug called TVB-3567, which may help treat acne. It checks the drug's safety and how the body processes it, first in healthy people and then in people with moderate to severe acne.
This trial tests an mRNA vaccine designed to treat mild facial acne. It aims to see if the vaccine is safe and effective at reducing acne lesions.
Hear when a new Acne trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.